Global Diagnostic Biomarker Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243354

Publication Date:

November 29, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Diagnostic Biomarker market size was valued at US$ million in 2023. With growing demand in downstream market, the Diagnostic Biomarker is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Diagnostic Biomarker market. Diagnostic Biomarker are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Diagnostic Biomarker. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Diagnostic Biomarker market.
Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Diagnostic Biomarker market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Diagnostic Biomarker market. It may include historical data, market segmentation by Type (e.g., S100, MART-1), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Diagnostic Biomarker market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Diagnostic Biomarker market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Diagnostic Biomarker industry. This include advancements in Diagnostic Biomarker technology, Diagnostic Biomarker new entrants, Diagnostic Biomarker new investment, and other innovations that are shaping the future of Diagnostic Biomarker.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Diagnostic Biomarker market. It includes factors influencing customer ' purchasing decisions, preferences for Diagnostic Biomarker product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Diagnostic Biomarker market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Diagnostic Biomarker market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Diagnostic Biomarker market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Diagnostic Biomarker industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Diagnostic Biomarker market.
Market Segmentation:
Diagnostic Biomarker market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others
Segmentation by application
Hospitals
Cancer Research Institutes
Diagnostic Labs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Biomarker Market Size 2019-2030
2.1.2 Diagnostic Biomarker Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Diagnostic Biomarker Segment by Type
2.2.1 S100
2.2.2 MART-1
2.2.3 Gp100
2.2.4 HMB45
2.2.5 AFP
2.2.6 BCR-ABL
2.2.7 Others
2.3 Diagnostic Biomarker Market Size by Type
2.3.1 Diagnostic Biomarker Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diagnostic Biomarker Market Size Market Share by Type (2019-2024)
2.4 Diagnostic Biomarker Segment by Application
2.4.1 Hospitals
2.4.2 Cancer Research Institutes
2.4.3 Diagnostic Labs
2.5 Diagnostic Biomarker Market Size by Application
2.5.1 Diagnostic Biomarker Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diagnostic Biomarker Market Size Market Share by Application (2019-2024)
3 Diagnostic Biomarker Market Size by Player
3.1 Diagnostic Biomarker Market Size Market Share by Players
3.1.1 Global Diagnostic Biomarker Revenue by Players (2019-2024)
3.1.2 Global Diagnostic Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Diagnostic Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Diagnostic Biomarker by Regions
4.1 Diagnostic Biomarker Market Size by Regions (2019-2024)
4.2 Americas Diagnostic Biomarker Market Size Growth (2019-2024)
4.3 APAC Diagnostic Biomarker Market Size Growth (2019-2024)
4.4 Europe Diagnostic Biomarker Market Size Growth (2019-2024)
4.5 Middle East & Africa Diagnostic Biomarker Market Size Growth (2019-2024)
5 Americas
5.1 Americas Diagnostic Biomarker Market Size by Country (2019-2024)
5.2 Americas Diagnostic Biomarker Market Size by Type (2019-2024)
5.3 Americas Diagnostic Biomarker Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Biomarker Market Size by Region (2019-2024)
6.2 APAC Diagnostic Biomarker Market Size by Type (2019-2024)
6.3 APAC Diagnostic Biomarker Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Diagnostic Biomarker by Country (2019-2024)
7.2 Europe Diagnostic Biomarker Market Size by Type (2019-2024)
7.3 Europe Diagnostic Biomarker Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Biomarker by Region (2019-2024)
8.2 Middle East & Africa Diagnostic Biomarker Market Size by Type (2019-2024)
8.3 Middle East & Africa Diagnostic Biomarker Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Diagnostic Biomarker Market Forecast
10.1 Global Diagnostic Biomarker Forecast by Regions (2025-2030)
10.1.1 Global Diagnostic Biomarker Forecast by Regions (2025-2030)
10.1.2 Americas Diagnostic Biomarker Forecast
10.1.3 APAC Diagnostic Biomarker Forecast
10.1.4 Europe Diagnostic Biomarker Forecast
10.1.5 Middle East & Africa Diagnostic Biomarker Forecast
10.2 Americas Diagnostic Biomarker Forecast by Country (2025-2030)
10.2.1 United States Diagnostic Biomarker Market Forecast
10.2.2 Canada Diagnostic Biomarker Market Forecast
10.2.3 Mexico Diagnostic Biomarker Market Forecast
10.2.4 Brazil Diagnostic Biomarker Market Forecast
10.3 APAC Diagnostic Biomarker Forecast by Region (2025-2030)
10.3.1 China Diagnostic Biomarker Market Forecast
10.3.2 Japan Diagnostic Biomarker Market Forecast
10.3.3 Korea Diagnostic Biomarker Market Forecast
10.3.4 Southeast Asia Diagnostic Biomarker Market Forecast
10.3.5 India Diagnostic Biomarker Market Forecast
10.3.6 Australia Diagnostic Biomarker Market Forecast
10.4 Europe Diagnostic Biomarker Forecast by Country (2025-2030)
10.4.1 Germany Diagnostic Biomarker Market Forecast
10.4.2 France Diagnostic Biomarker Market Forecast
10.4.3 UK Diagnostic Biomarker Market Forecast
10.4.4 Italy Diagnostic Biomarker Market Forecast
10.4.5 Russia Diagnostic Biomarker Market Forecast
10.5 Middle East & Africa Diagnostic Biomarker Forecast by Region (2025-2030)
10.5.1 Egypt Diagnostic Biomarker Market Forecast
10.5.2 South Africa Diagnostic Biomarker Market Forecast
10.5.3 Israel Diagnostic Biomarker Market Forecast
10.5.4 Turkey Diagnostic Biomarker Market Forecast
10.5.5 GCC Countries Diagnostic Biomarker Market Forecast
10.6 Global Diagnostic Biomarker Forecast by Type (2025-2030)
10.7 Global Diagnostic Biomarker Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Information
11.1.2 Biocrates Life Sciences Diagnostic Biomarker Product Offered
11.1.3 Biocrates Life Sciences Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biocrates Life Sciences Main Business Overview
11.1.5 Biocrates Life Sciences Latest Developments
11.2 Augurex Life Sciences
11.2.1 Augurex Life Sciences Company Information
11.2.2 Augurex Life Sciences Diagnostic Biomarker Product Offered
11.2.3 Augurex Life Sciences Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Augurex Life Sciences Main Business Overview
11.2.5 Augurex Life Sciences Latest Developments
11.3 Biomedical
11.3.1 Biomedical Company Information
11.3.2 Biomedical Diagnostic Biomarker Product Offered
11.3.3 Biomedical Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Biomedical Main Business Overview
11.3.5 Biomedical Latest Developments
11.4 Target Discovery
11.4.1 Target Discovery Company Information
11.4.2 Target Discovery Diagnostic Biomarker Product Offered
11.4.3 Target Discovery Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Target Discovery Main Business Overview
11.4.5 Target Discovery Latest Developments
11.5 Banyan Biomarkers
11.5.1 Banyan Biomarkers Company Information
11.5.2 Banyan Biomarkers Diagnostic Biomarker Product Offered
11.5.3 Banyan Biomarkers Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Banyan Biomarkers Main Business Overview
11.5.5 Banyan Biomarkers Latest Developments
11.6 Astute Medical
11.6.1 Astute Medical Company Information
11.6.2 Astute Medical Diagnostic Biomarker Product Offered
11.6.3 Astute Medical Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Astute Medical Main Business Overview
11.6.5 Astute Medical Latest Developments
11.7 Axela
11.7.1 Axela Company Information
11.7.2 Axela Diagnostic Biomarker Product Offered
11.7.3 Axela Diagnostic Biomarker Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Axela Main Business Overview
11.7.5 Axela Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂